BRAF D549G
|
CRC
|
BRAF D549G
|
CRC
|
cetuximab Resistant: C4 – Case Studies
|
cetuximab Resistant: C4 – Case Studies
|
BRAF D549G
|
Melanoma
|
BRAF D549G
|
Melanoma
|
U0126 Resistant: D – Preclinical
|
U0126 Resistant: D – Preclinical
|
BRAF D549G
|
Melanoma
|
BRAF D549G
|
Melanoma
|
sorafenib Sensitive: D – Preclinical
|
sorafenib Sensitive: D – Preclinical
|